Source: cases/15usc1/f-supp-2d-385-740-north-jackson-pharmacy-v-caremark.case
Case source: https://www.neochart.com/catalog/cases/f-supp-2d/volume_385/0740_01/index.html
But where in contrast buyers join together in a productive venture, cooperative buying is rarely viewed as a per se unlawful restraint under Section 1 so long as it contributes to the productive enterprise.
And because the alleged anticompetitive agreement between Plan Sponsors is ancillary to that arrangement, it will be assessed under the more probing analysis offered by the rule of reason.
Under United States v. Masonite Corp., 316 U.S. 265, 276, 62 S.Ct. 1070, 86 L.Ed. 1461 (1942) the Plan Sponsors’ knowledge of and acquiescence in that common strategy could reasonably support a finding of conspiracy under Section 1.
For purposes of Pharmacy’s common agent claim, the relevant agreement is that alleged to exist among the Plan Sponsors. And that agreement, between firms that would normally compete with each other for the purchase of prescription drugs, may fairly be said to constitute a horizontal restraint.
Naked restraints are unlikely to have any redeeming value and so are usually accorded per se treatment. But ancillary restraints that “may contribute to the success of a cooperative venture that promises greater productivity and output” (id. at 189) demand the more thorough analysis provided by the rule of reason.
Caremark implicitly concedes that the conspiracy alleged in Claim II — ’that between Caremark and other PBMs to fix drug prices — would if proved constitute a naked horizontal price-fixing agreement subject to per se treatment.
there appears to be no authority (and indeed none is found in the cases North Jackson cites) to support the notion that substantial market power is a sufficient, rather than a necessary, basis for finding that a given restraint is per se unlawful under Section 1
casedsl 1
case /f-supp-2d/385/0740-01
name North Jackson Pharmacy, Inc. v. Caremark Rx, Inc.
cite 385 F. Supp. 2d 740 (2005)
court United States District Court for the Northern District of Illinois
date 2005-08-12
url catalog/cases/f-supp-2d/volume_385/0740_01/index.html
source ir/caselaw/f_supp_2d_385.jsonl sha1=a388ed0a9e4a9477a6dc305edf64c5cc84850e51 chars=31109
law 15usc1
role rule-announced
posture civil; putative class action by independent pharmacies against pharmacy benefits manager; after denial of 12(b)(6), defendant's Rule 16 issue-narrowing motion to fix rule of reason (not per se) as the standard for Claim I; granted
result not-decided
element restraint.per-se : not-reached
count Claim I (common-agent claim)
party Plan Sponsors, acting through Caremark as their common agent
variant ancillary-restraint/cooperative-buying-through-common-agent
fact @3665..3833 [supports] | Over 1,200 of such Plan Sponsors have hired Care-mark to help control the cost of prescription drugs for their employees or members (“Plan Subscribers”) (SAC ¶¶15, 29).
fact @4612..4866 [supports] | In return for inclusion in Caremark’s network and access to the large volume of business that such inclusion brings, North Jackson must agree to dispense drugs to Plan Subscribers at a discount from prices charged to its cash-paying customers (SAC ¶ 30).
fact @13830..14013 [cuts-against] | By negotiating prescription drug reimbursement rates on behalf of the 1,200 Plan Sponsors it represents, Caremark acts on behalf of what is essentially a cooperative purchasing group.
fact @22123..22336 [cuts-against] | Caremark specializes in various functions of benefit plan administration and is likely able to achieve economies of scale in the performance of those functions that would otherwise be unavailable to Plan Sponsors.
fact @22337..22509 [cuts-against] | And the creation of retail pharmacy networks, which necessarily involves the setting of reimbursement rates, undoubtedly contributes to the success of that larger endeavor.
rule @18624..18830 | But where in contrast buyers join together in a productive venture, cooperative buying is rarely viewed as a per se unlawful restraint under Section 1 so long as it contributes to the productive enterprise.
held @24868..25056 | And because the alleged anticompetitive agreement between Plan Sponsors is ancillary to that arrangement, it will be assessed under the more probing analysis offered by the rule of reason.
gloss Buyer-side price setting by competing payors through a shared intermediary is a real horizontal restraint, but it is bundled with claims processing, formularies, rebates and network building, and its immediate effect is lower consumer prices; the per se label in the complaint does not bind the court.
gloss Mode of analysis only: per se treatment is refused and the rule of reason selected for Claim I; whether the restraint is unreasonable is expressly left open, so this is not a not-satisfied finding. Polarity here is relative to "per se treatment applies". The court's general naked-vs-ancillary rule sentence (@16295) is filed under the Claim II block.
element agreement : satisfied [pleaded]
role applied
count Claim I
variant hub-and-spoke/buyers-knowingly-sharing-common-purchasing-agent
fact @6180..6372 [supports] | Claim I asserts a conspiracy between Plan Sponsors, using Caremark as their “common agent,” to fix the prices paid independent pharmacies for dispensing prescription drugs to Plan Subscribers.
rule @11894..12126 | Under United States v. Masonite Corp., 316 U.S. 265, 276, 62 S.Ct. 1070, 86 L.Ed. 1461 (1942) the Plan Sponsors’ knowledge of and acquiescence in that common strategy could reasonably support a finding of conspiracy under Section 1.
held @12421..12715 | For purposes of Pharmacy’s common agent claim, the relevant agreement is that alleged to exist among the Plan Sponsors. And that agreement, between firms that would normally compete with each other for the purchase of prescription drugs, may fairly be said to constitute a horizontal restraint.
gloss Court rejects the characterisation of 1,200 separate vertical contracts: the relevant agreement is the horizontal one among the spokes (pleading sufficiency was decided earlier by adopting the transferor court's opinion).
element restraint.per-se : not-reached
count Claim II
party Caremark and rival PBMs
variant horizontal-price-fixing/competing-intermediaries-fixing-reimbursement-rates
fact @6373..6477 [supports] | Claim II charges a conspiracy between Caremark and PBMs with which it competes to fix those same prices.
rule @16295..16610 | Naked restraints are unlikely to have any redeeming value and so are usually accorded per se treatment. But ancillary restraints that “may contribute to the success of a cooperative venture that promises greater productivity and output” (id. at 189) demand the more thorough analysis provided by the rule of reason.
held @8548..8775 | Caremark implicitly concedes that the conspiracy alleged in Claim II — ’that between Caremark and other PBMs to fix drug prices — would if proved constitute a naked horizontal price-fixing agreement subject to per se treatment.
gloss Only the mode of analysis is conceded, and only conditionally ("if proved"); existence of the PBM-PBM agreement is untested, so nothing is satisfied. The rule line is the court's general statement that naked restraints get per se treatment; its second sentence is the ancillary-restraint rule the court applies to Claim I.
element restraint.market-power : not-reached
rule @29159..29421 | there appears to be no authority (and indeed none is found in the cases North Jackson cites) to support the notion that substantial market power is a sufficient, rather than a necessary, basis for finding that a given restraint is per se unlawful under Section 1
gloss Market power is necessary under the rule of reason but cannot convert a restraint into a per se violation; whether Caremark has it is not decided.
element restraint.rule-of-reason : not-reached
count Claim I
gloss Selected as the governing standard for Claim I (the selection itself is recorded in the restraint.per-se Claim I block); the court expressly withholds any view on ultimate lawfulness.
element injury : not-reached
element standing : not-reached
element commerce : not-reached
misfit v1 records a mode-of-analysis ruling as rule-announced / not-reached, which stops it being read as a finding, but WHICH mode was selected (rule of reason for Claim I; per se conceded-if-proved for Claim II) lives only in gloss and variant text. There is no structured "mode-selected: <mode>" value, and two blocks under the same id restraint.per-se here point in opposite directions.
misfit The case-level role is rule-announced, so every block inherits it and must carry a `rule` quote; bare not-reached blocks (and restraint.rule-of-reason, which is the standard actually selected but has no quote of its own) had to be given `role background` to pass the checker. "Element not touched in a rule-announcing opinion" has no role value.
misfit Rule 16 issue-narrowing is a posture with no natural result: no claim is won, lost or remanded; `not-decided` is the closest, yet a significant legal ruling against the claimant was made.
misfit The facts are a hybrid of complaint allegations and "undisputed facts in the parties' submissions" plus agency reports (FTC statement, FTC/DOJ report) taken as legislative facts; a not-reached block carries no basis, so the epistemic status of its fact lines (alleged / undisputed / legislative) is unrecorded.
misfit The defendant (Caremark) is not itself a party to the horizontal agreement in Claim I; it is the agent/hub of an agreement among non-party Plan Sponsors. The notation cannot express hub-vs-spoke roles or that the conspirators are non-parties.
misfit The procompetitive-justification / ancillarity analysis (efficiencies of the larger venture) is the heart of the opinion; it has no element of its own and is folded into restraint.per-se as the reason per se treatment fails.
misfit The `rule` under agreement is the court applying Masonite, with the citation embedded in the sentence; rule lines that are citation sentences are noisy for the law side.